Diabetes, obesity & metabolism
Sex differences in trial representation and the cardiovascular effectiveness of newer glucose-lowering agents in patients with and without type 2 diabetes: A systematic review and meta-analysis of cardiovascular outcome trials.
Magdaline Zawadka, Erwin Taguiam, Mê-Linh Lê, Rohan Sanjanwala, Shuangbo Liu, Ashish H Shah, Setor K Kunutsor
Published: 202610.1111/dom.70411
Abstract
AIMS: The extent to which the cardiovascular benefits of sodium-glucose co-transporter 2 inhibitors (SGLT-2is) and glucagon-like peptide 1 receptor agonists (GLP-1RAs) differ by sex remains unclear. This systematic meta-analysis aimed to investigate…
Preview only. Read the full abstract at the source